Page last updated: 2024-11-05

ici 204,219 and Cystic Fibrosis

ici 204,219 has been researched along with Cystic Fibrosis in 2 studies

zafirlukast: a leukotriene D4 receptor antagonist

Cystic Fibrosis: An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Conway, SP1
Etherington, C1
Peckham, DG1
Whitehead, A1
Santais, MC1
Callens, E1
Djebbar, R1
Ruff, F1

Reviews

1 review available for ici 204,219 and Cystic Fibrosis

ArticleYear
[Potential importance of antileukotrienes in the treatment of asthma and other inflammatory diseases: apropos of a new pharmacological class].
    La Revue de medecine interne, 1998, Volume: 19, Issue:2

    Topics: Acetophenones; Adult; Animals; Anti-Asthmatic Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthr

1998

Trials

1 trial available for ici 204,219 and Cystic Fibrosis

ArticleYear
A pilot study of zafirlukast as an anti-inflammatory agent in the treatment of adults with cystic fibrosis.
    Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2003, Volume: 2, Issue:1

    Topics: Adult; Anti-Inflammatory Agents; Cystic Fibrosis; Female; Humans; Indoles; Leukotriene Antagonists;

2003